Log in

NASDAQ:INMBINmune Bio Earnings Date, Estimates & History

+0.05 (+1.52 %)
(As of 04/9/2020 01:33 AM ET)
Today's Range
Now: $3.35
50-Day Range
MA: $3.70
52-Week Range
Now: $3.35
Volume5,500 shs
Average Volume30,644 shs
Market Capitalization$36.00 million
P/E RatioN/A
Dividend YieldN/A


INmune Bio (NASDAQ:INMB) Earnings Information

INmune Bio last announced its quarterly earnings data on March 11th, 2020. The reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.25) by $0.03. INmune Bio has generated ($0.75) earnings per share over the last year. INmune Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 10th, 2020 based off prior year's report dates.

INmune Bio Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INmune Bio (NASDAQ:INMB) Earnings Estimates

2020 EPS Consensus Estimate: ($0.70)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.14)($0.14)($0.14)
Q2 20201($0.14)($0.14)($0.14)
Q3 20201($0.19)($0.19)($0.19)
Q4 20201($0.23)($0.23)($0.23)

INmune Bio (NASDAQ INMB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/12/2019Q2 2019($0.20)($0.04)($0.04)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel